SCA

SCA applies surprisal-based dimensionality reduction to single-cell transcriptomic datasets to detect rare and subtle cellular subpopulations and to improve downstream imputation.


Key Features:

  • Surprisal-based dimensionality reduction: Uses the information-theoretic concept of surprisal to derive components from single-cell transcriptomic data.
  • Detection of subtle variations: Emphasizes small or nuanced transcriptional differences that are often missed by conventional dimensionality reduction methods.
  • Identification of rare subpopulations: Highlights rare or clinically significant cell populations, including specific cytotoxic T-cell subsets.
  • Improved imputation: Produces representations that improve downstream imputation and reconstruction of missing transcriptomic values.
  • Information-theoretic framework: Employs an efficient information-theoretic approach for signal extraction from complex biological datasets.

Scientific Applications:

  • Single-cell transcriptomic analysis: Characterizing cellular heterogeneity within single-cell RNA-seq datasets.
  • Detection of rare cell types: Identifying rare or small cellular subpopulations such as cytotoxic T-cell subsets.
  • Study of complex tissues: Analyzing cellular composition and variation in complex biological tissues in health and disease contexts.
  • Support for therapeutic research: Providing enhanced signals that inform personalized medicine and therapeutic intervention studies.

Methodology:

Computes surprisal scores from single-cell transcriptomic measurements and applies surprisal-based dimensionality reduction, with resulting components used to improve downstream imputation.

Topics

Details

License:
MIT
Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Python
Added:
3/6/2024
Last Updated:
11/24/2024

Operations

Publications

DeMeo B, Berger B. SCA: recovering single-cell heterogeneity through information-based dimensionality reduction. Genome Biology. 2023;24(1). doi:10.1186/s13059-023-02998-7. PMID:37626411. PMCID:PMC10464206.

PMID: 37626411
Funding: - National Institutes of Health: 1R35GM141861, R01HG010959

Documentation

Links